|
|
|
|
|
1
|
The Rheumatoid Arthritis Market Competitive Landscape and Clinical Stage Analysis |
May 2009 |
$1,495.00 |
|
Rheumatoid arthritis, a systemic disease characterized by inflammation of the membrane lining the joint, is one of the most common forms of arthritis. Up to 50 percent of all rheumatoid arthritis patients enter early retirement
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
2
|
Cancer Therapeutics: Market Insight & Pipeline Analysis |
Aug 2008 |
$3,500.00 |
|
Objectives and Scope
The intention of this study is to provide a detailed and thorough analysis of the present and future global market for cancer therapeutics. This report analyzes in detail the markets for colorectal
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
3
|
Evidence-Based Medicine: Current Use and Future Impact on Global Clinical and Reimbursement Practices |
May 2008 |
$2,999.00 |
|
Evidence-based medicine is defined as an attempt to use standards from scientifically-collected evidence to improve medical practices by assessing risks and benefits of treatments and/or the lack of treatments. The term can be taken to
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
4
|
The Global Pain Therapeutics Market Market Analysis, R&D Pipelines and Competitive Landscape |
Oct 2007 |
$2,999.00 |
|
One in five people suffer from moderate to severe chronic pain, and one in three is unable or less able to maintain an independent lifestyle due to their pain. Between 50 and 60 percent of
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
5
|
The Global Antibacterials Market: R&D Pipelines, Market Analysis and Competitive Landscape |
Aug 2007 |
$2,499.00 |
|
The global anti-infective market is currently valued at US$66.5 billion with antibacterial agents accounting for over 50% of sales. The antibacterial market is set to grow to over US$45.0 billion by 2012, driven by the
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
6
|
The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape |
May 2007 |
$2,499.00 |
|
The global anti-infective market is currently valued at US$66.5 billion with antiviral agents accounting for 24% of sales (excluding vaccines which target viral infectious diseases).
According to Arrowhead Publishers’ new report The Antivirals Market:
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
7
|
Outsourcing Clinical Trials: A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index |
May 2007 |
$2,999.00 |
|
Offshoring clinical trials to emerging markets around the world is receiving increasing attention as a very attractive alternative in the clinical development process. This follows as a natural reaction to already successful offshoring activities in
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
8
|
Innovations and Trends in Clinical Trials: Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology |
Mar 2007 |
$2,250.00 |
|
The clinical trials industry has clear potential for strong growth in the future, driven by technological and scientific advances. This trend is complemented by the development of new trial designs, with a view to rationalizing
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
9
|
Neurodegenerative Disorder Therapies |
Jan 2007 |
$2,250.00 |
|
With a market size of US$14.5 billion in 2005 and an anticipated value of US$16.5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech industry. An increase in the number
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
10
|
Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight |
Jan 2007 |
$2,250.00 |
|
In 2005, the antibodies market was valued at an estimated US$14 billion, accounting for over 24 percent of the total protein therapeutics market. This share increased substantially since 2001, when it barely surpassed 13 percent.
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
11
|
The Global Protein Therapeutics Market: Market Dynamics and Pipeline Analysis |
Dec 2006 |
$3,250.00 |
|
The global protein therapeutics market was valued at US$57 billion in 2005. Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of the key products presently available in the category.
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
12
|
Injectable Drug Delivery: Market Impact and Industry Trends |
Oct 2006 |
$1,750.00 |
|
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The search for more efficient drug delivery systems is also being driven
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
13
|
Rheumatoid Arthritis: Market Trends and R&D Insights |
Sep 2006 |
$1,250.00 |
|
"The market for rheumatoid arthritis therapeutics has experienced remarkably strong growth during the past five years due to the introduction of the biological response modifiers (BRMs) to treatment regimens. The value of this market
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
14
|
The Prescribing Data Restriction Program: Critical Assessment and Best Practices |
Sep 2006 |
$1,500.00 |
|
Since the mid-1990s, pharma companies have devised their sales and marketing strategies based on Rx data. However, with the introduction of the AMA's Prescribing Data Restriction Program (PDRP) opt-out program in July 2006, pharma companies
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
15
|
The Global Diabetes Market: Therapeutics, Diagnostics and Complications |
Aug 2006 |
$2,499.00 |
|
Diabetes is one of the largest therapeutic segments of global pharmaceutical sales and during the last 10 years it has grown by a compound average growth rate of nearly 20% from around US$4 billion in
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
16
|
The Global Drug Delivery Market: Research Trends and Market Outlook |
May 2006 |
$1,999.00 |
|
The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
17
|
Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition |
May 2006 |
$2,999.00 |
|
Despite their diversity, global healthcare systems are increasingly converging in the need and desire to contain
costs of healthcare, and especially those associated with pharmaceuticals. At the same time, Big Pharma are
having
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
18
|
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006 |
Mar 2006 |
$1,999.00 |
|
Despite their diversity, global healthcare systems are increasingly converging in the need and desire to contain costs of healthcare, and especially those associated with pharmaceuticals. At the same time, Big Pharma are having
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
19
|
Cancer Therapeutics 2006: Market Dynamics and R&D Trends |
Dec 2005 |
$2,500.00 |
|
Together, the four major cancer markets, which include colorectal, prostate, lung and breast cancer were valued at well over $16 billion in 2005, which was an increase of 14 percent in value since 2004.
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
20
|
Amgen: Profile, Patents and Pipeline |
Aug 2005 |
$499.00 |
|
Amgen is the world’s largest biotechnology company and the eighth largest pharmaceutical company worldwide. Revenues have nearly doubled in the last three years, going from $5.52 billion in 2002 to $10.55 billion in 2004.
more...
Published by: Arrowhead Publishers
|
|
|
21
|
US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts |
Jul 2005 |
$1,125.00 |
|
The US generics market was estimated at US$18.1 billion in 2004; the leading European generics markets together totalled between US$10-US$11 billion for the same period. This new report asks why there is such
more...
Published by: Arrowhead Publishers
|
|
|
22
|
Pain Therapeutics 2005: Market Dynamics and Outlook |
May 2005 |
$1,999.00 |
|
Pain Therapeutics 2005: Market Dynamics and Outlook provides detailed analysis and information
concerning the global market for pain therapeutics, R&D pipelines and company involvement in this
field.
About one and a half billion people
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
23
|
Strategies for Innovation in Pharmaceutical R&D: Enhancing R&D Through Biotech Alliances and CRO Outsourcing |
Apr 2005 |
$750.00 |
|
This new report has been written to provide members of pharmaceutical, biotechnology and clinical research sectors an analytically-based overview of the mechanisms of the partnering process, and the key issues and trends affecting these arrangements.
more...
Published by: Arrowhead Publishers
|
|
|
24
|
Biogenerics: Challenges and Promise |
Jan 2005 |
$999.00 |
|
This brand new report published in November 2004 takes an insightful look at the burgeoning biogenerics industry.
This report primarily focuses on how the generics industry will be shaped by the global
more...
Published by: Arrowhead Publishers
| Search inside this report |
|
|
25
|
Cancer Vaccines: Measuring Market Potential |
Oct 2004 |
$1,500.00 |
|
This brand new report published in October 2004 provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets.
Vaccine product candidates are
more...
Published by: Arrowhead Publishers
|
|
|
|
|
|
0 items
